S
Stifel Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
426
Ligand Pharmaceuticals
LGND
$3.24B
|
AS
Annabel Samimy
| $165.97 | $143 |
14%
downside
| Buy |
10 Apr ‘25
5 months ago |
|
427
Quanta Services
PWR
$58.1B
|
SE
Stanley Elliott
| $390.17 | $287 |
26%
downside
| Buy |
9 Apr ‘25
5 months ago |
|
428
Nurix Therapeutics
NRIX
$684M
|
SW
Stephen Willey
| $8.95 | $35 |
291%
upside
| Buy |
9 Apr ‘25
5 months ago |
|
429
Walmart
WMT
$801B
|
MA
Mark Astrachan
| $100.41 | $91 |
9%
downside
| Hold |
9 Apr ‘25
5 months ago |
|
430
Levi Strauss
LEVI
$8.59B
|
DC
Drew Crum
| $21.71 | $20 |
8%
downside
| Buy |
8 Apr ‘25
5 months ago |
|
431
Alignment Healthcare
ALHC
$3.26B
|
CJ
Craig Jones
| $16.45 | $23 |
40%
upside
| Buy |
8 Apr ‘25
5 months ago |
|
432
DigitalOcean
DOCN
$3.11B
|
BR
Brad Reback
| $34.19 | $33 |
3%
downside
| Hold |
7 Apr ‘25
5 months ago |
|
433
RH
RH
$4.29B
|
WAC
W. Andrew Carter
| $228.93 | $390 |
70%
upside
| Buy |
7 Apr ‘25
5 months ago |
|
434
Bausch + Lomb
BLCO
$5.31B
|
TS
Tom Stephan
| $15 | $15 |
0%
upside
| Hold |
3 Apr ‘25
5 months ago |
|
435
Spire Global
SPIR
$278M
|
ER
Erik Rasmussen
| $8.94 | $18 |
101%
upside
| Buy |
1 Apr ‘25
5 months ago |
|
436
Revolution Medicines
RVMD
$7.56B
|
BB
Benjamin Burnett
| $40.45 | $64 |
58%
upside
| Buy |
1 Apr ‘25
5 months ago |
|
437
ClearPoint Neuro
CLPT
$299M
|
MB
Mathew Blackman
| $10.53 | $25 |
137%
upside
| Buy |
1 Apr ‘25
5 months ago |
|
438
Alnylam Pharmaceuticals
ALNY
$61.5B
|
PM
Paul Matteis
| $469.31 | $345 |
26%
downside
| Buy |
31 Mar ‘25
5 months ago |
|
|
KMTS
439
Kestra Medical Technologies, Ltd. Common Stock
KMTS
$934M
|
RW
Rick Wise
| $18.19 | $28 |
54%
upside
| Buy |
31 Mar ‘25
5 months ago |
|
440
Soleno Therapeutics
SLNO
$3.19B
|
JC
James Condulis
| $60.02 | $108 |
80%
upside
| Buy |
28 Mar ‘25
5 months ago |
|
441
Braze
BRZE
$3.35B
|
PL
Parker Lane
| $30.08 | $50 |
66%
upside
| Buy |
28 Mar ‘25
5 months ago |
|
442
Paychex
PAYX
$47.9B
|
BB
Bryan Bergin
| $133.07 | $156 |
17%
upside
| Hold |
27 Mar ‘25
5 months ago |
|
443
Cintas
CTAS
$81.2B
|
SR
Shlomo Rosenbaum
| $201.40 | $204 |
1%
upside
| Hold |
26 Mar ‘25
5 months ago |
|
|
PVLA
444
Palvella Therapeutics, Inc. Common Stock
PVLA
$661M
|
AS
Annabel Samimy
| $59.73 | $45 |
25%
downside
| Buy |
26 Mar ‘25
5 months ago |
|
445
Avalo Therapeutics
AVTX
$145M
|
AT
Alex Thompson
| $11.02 | $36 |
227%
upside
| Buy |
25 Mar ‘25
5 months ago |
|
446
Crinetics Pharmaceuticals
CRNX
$3.3B
|
AT
Alex Thompson
| $35 | $60 |
71%
upside
| Buy |
25 Mar ‘25
5 months ago |
|
447
Mativ Holdings
MATV
$666M
|
LK
Lars Kjellberg
| $12.19 | $10 |
18%
downside
| Buy |
24 Mar ‘25
5 months ago |
|
448
Vor Biopharma
VOR
$228M
|
SW
Stephen Willey
| $1.80 | $5 |
178%
upside
| Buy |
21 Mar ‘25
5 months ago |
|
449
Darden Restaurants
DRI
$24.7B
|
CO
Chris O'Cull
| $211.46 | $215 |
2%
upside
| Buy |
21 Mar ‘25
5 months ago |
|
450
Costco
COST
$424B
|
MA
Mark Astrachan
| $956.29 | $1,035 |
8%
upside
| Buy |
20 Mar ‘25
5 months ago |
|